Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology
Year: 2024
Type: article
Source: Kidney International
Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, University of Cincinnati, University of Minnesota, American University of Beirut, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Stanford Medicine, Stanford University, The University of Texas Health Science Center at Houston, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Northwell Health, Hofstra University, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, University Health Network, University of Toronto
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations, Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation, Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
OpenAlex ID: W4403668052
